✦ LIBER ✦

2010 International consensus conference on liver transplantation for hepatocellular carcinoma: Texts of experts

✍ Scribed by Mickael Lesurtel; Pierre-Alain Clavien

Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 134 KB
Volume: 17
Category: Article
ISSN: 1527-6465
DOI: 10.1002/lt.22350

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Report of the first international liver

Report of the first international liver transplantation society expert panel consensus conference on renal insufficiency in liver transplantation

✍ Michael R. Charlton; William J. Wall; Akinlolu O. Ojo; Pere Ginés; Stephen Texto 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 602 KB

Summary of candidate selection and expan

Summary of candidate selection and expanded criteria for liver transplantation for hepatocellular carcinoma: A review and consensus statement

✍ K. Raj Prasad; Richard S. Young; Patrizia Burra; Shu-Sen Zheng; Vincenzo Mazzafe 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB

Liver transplantation (LT) is accepted as the standard treatment for select patients with hepatocellular carcinoma (HCC) and chronic liver disease. LT achieves oncological clearance and treats the underlying chronic liver disease. The gap between the demand for cadaveric organs and the supply necess

Improved results of transplantation for

Improved results of transplantation for hepatocellular carcinoma: A report from the international registry of hepatic tumors in liver transplantation

✍ Nicholas Onaca; Gary L. Davis; Linda W. Jennings; Robert M. Goldstein; Goran B. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB 👁 1 views

Improved outcome after liver transplantation (LTX) for hepatocellular carcinoma (HCC) made LTX a legitimate treatment of the disease. We analyzed trends of LTX for HCC with tumors known before transplantation in 902 patients in a large international registry across 3 periods: 1983-1990, 1991-1996, a

Expanded criteria for liver transplantat

Expanded criteria for liver transplantation in patients with hepatocellular carcinoma: A report from the International Registry of Hepatic Tumors in Liver Transplantation

✍ Nicholas Onaca; Gary L. Davis; Robert M. Goldstein; Linda W. Jennings; Göran B. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 344 KB 👁 2 views

Hepatocellular carcinoma (HCC) is a common indication for liver transplantation (LT). Currently, deceased donor LT is approved by the United Network for Organ Sharing for patients with HCC who meet the Milan criteria of a single tumor up to 5 cm or up to 3 tumors up to 3 cm as determined by imaging

Management of hepatocellular carcinoma o

Management of hepatocellular carcinoma on the waiting list before liver transplantation: Time for controlled trials?

✍ Pietro Majno; Emiliano Giostra; Gilles Mentha 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB

Francisco; RFTA, radiofrequency thermal ablation; TACE, transarterial chemoembolization; UNOS, United Network for Organ Sharing. This article is based on a review of the treatment of hepatocellular carcinoma while patients are on a liver transplant waiting list that our group published in Journal of

Impact of pretransplantation transarteri

Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma

✍ Thomas Decaens; Françoise Roudot-Thoraval; Solange Bresson-Hadni; Carole Meyer; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB

The actual impact of transarterial chemoembolization before liver transplantation (LT) for hepatocellular carcinoma (HCC) on patient survival and HCC recurrence is not known. Between 1985 and 1998, 479 patients with HCC in 14 French centers were evaluated for LT. Among these 479 patients, this case-